Alicer Andrew, PhD
I am deeply committed to research aimed at improving the quality of life in underserved and marginalized communities. My earlier work focused on discovering novel therapeutic targets that improve pregnancy outcomes during acute malaria infection. Currently, I am using mass cytometry (CyTOF) to study T cell phenotypes and function in a diverse cohort ofpeople with HIV, including elite-controllers and individuals who initiated antiretroviral therapy during either acute or chronic HIV infection. My goal is to understand the relationship between timing of antiretroviral therapyand T cell functionality and provide insights into the T cell profiles associated with immune preservation and HIV control.